Rasagiline in Participants Treated With Levodopa/Carbidopa Therapy
- Study Title
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
- Teva Identifier
- TVP - 1012/135 Double Blind
- ClinicalTrials.gov Identifier
- NCT00203177
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: rasagiline mesylate | Drug: rasagiline mesylate 1.0 mg
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years and older
- Trial Duration
- 10/01/2001 - 01/00/1900
- Phase
- Phase 3
